Is Hydrocodone legal in United Arab Emirates?

Legal status

Hydrocodone is placed in Schedule 1 of Decision No. 158 of 2025 at the printed entry «هيدروكودون». The dossier's point about this row is that medical use does not move the placement: hydrocodone is a widely prescribed oral opioid and it is nonetheless in the narcotics schedule proper, so lawful prescribing elsewhere does not erase the schedule based criminal route for unauthorised conduct here. The entry names the substance alone, with no combination product limb, which matters because hydrocodone is usually dispensed in fixed combinations, and the placement follows the controlled component rather than the product name on the box. The row runs through Articles 10, 41 and 57, with Schedule 10 carrying the quantity bands. The placement was read on 20 September 2026.

Consequences if caught

Schedule 1 is one of the four schedule groups Article 57 names, and hydrocodone's entry is in Schedule 1, so the capital route reaches a prescription opioid on the same footing as an illicit one. The dossier records Article 57 as stating mandatory death for its trafficking or promotion trigger and as stating no quantity, and records that the Schedule 10 bands do not gate that route. What separates lawful from unlawful on this row is therefore the authorisation and the conduct, not the number of tablets, and a quantity based intuition imported from a domestic prescribing rule will not describe the exposure correctly. Article 41 carries the personal use route for this branch, with no tariff stated in the dossier.

If prescribed or medical

The dossier records at the modafinil row that a 268 entry ministry travellers list was checked and expressly not used as a schedule. Attached to this substance: hydrocodone is in Schedule 1 and the entry names the opioid rather than any combination product, so a cough or analgesic preparation containing it is inside the placement regardless of what the product is called. The dossier records no prescribing route, no import permit procedure and no quantity allowance for travellers, so the question of what a patient may bring is deferred rather than answered.

Documentation

Carry the prescription and the original dispensing packaging showing the active ingredient rather than only the brand, because the placement attaches to hydrocodone and a brand name does not disclose it. On this record those documents are evidence about a medicine that is in Schedule 1, and no Emirati permit procedure is described in the dossier that would convert them into an authorisation. Provenance: the Schedule 1 placement and the entry «هيدروكودون» were read on 20 September 2026, with the capital analysis resting on Article 57 and not on the Schedule 10 bands.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with United Arab Emirates’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.